Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00291083 · ClinicalTrials.gov registry record
Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer
A clinical trial, sponsored by Carol Fabian, MD.
- Completed
- Registry status
- 229
- Enrollment target
NCT00291083: Completed study, sponsored by Carol Fabian, MD.
NCT00291083 is a clinical trial that has completed, run by Carol Fabian, MD. The registered enrollment target is 229 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00291083 has completed, sponsored by Carol Fabian, MD.
- COMPLETED
- Registry status
- 229 participants
- Enrollment target
Study Summary
To examine nipple aspirate fluid for secretions that may be identified as a high risk indicator for development of breast cancer, and compare those to serum analysis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 229 participants |
| Start Date | 2005-10 |
| Est. Completion | 2008-06 |
What the finished NCT00291083 record still lists
NCT00291083 is an observational study that tracks outcomes without assigning an intervention. The registered 229 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00291083 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00291083 about?
NCT00291083 is a clinical study titled "Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer". To examine nipple aspirate fluid for secretions that may be identified as a high risk indicator for development of breast cancer, and compare those to serum analysis.
What is the current status of trial NCT00291083?
This trial is currently completed. The enrollment target is 229 participants. The study started on 2005-10. Estimated completion is 2008-06.
Who is sponsoring clinical trial NCT00291083?
This trial is sponsored by Carol Fabian, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia